Skip to Content

IP 253 (Ranitidine Hydrochloride 150 mg)

Pill with imprint IP 253 is Orange, Round and has been identified as Ranitidine Hydrochloride 150 mg. It is supplied by Amneal Pharmaceuticals.

Ranitidine is used in the treatment of duodenal ulcer; erosive esophagitis; gerd; duodenal ulcer prophylaxis; cutaneous mastocytosis and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Ranitidine 150 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for IP 253

Ranitidine hydrochloride 150 mg IP 253
Ranitidine hydrochloride 150 mg IP 253
Ranitidine hydrochloride 150 mg IP 253
Ranitidine hydrochloride 150 mg IP 253
Ranitidine hydrochloride 150 mg IP 253  Front
Ranitidine hydrochloride 150 mg IP 253  Back
Ranitidine hydrochloride 150 mg IP 253
Ranitidine hydrochloride 150 mg IP 253

Ranitidine Hydrochloride

Imprint
IP 253
Strength
150 mg
Color
Orange
Size
9.00 mm
Shape
Round
Availability
Rx and/or OTC
Drug Class
H2 antagonists
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Amneal Pharmaceuticals

Labelers / Repackagers

NDC CodeLabeler / Repackager
53746-0253 Amneal Pharmaceuticals LLC
65162-0253 Amneal Pharmaceuticals LLC
63739-0489 McKesson Packaging Services
68084-0717 Amerisource Health Services
42291-0724 AvKare, Inc.
66267-0188 Nucare Pharmaceuticals Inc. (repackager)
68071-1321 Nucare Pharmaceuticals Inc. (repackager)

Get help with Imprint Code FAQs.

Related Images for "IP 253"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.